Related Experiment Videos
Relevance of reactivity in commercially available hepatitis C virus antibody assays
S Polywka1, M Schröter, H H Feucht
1polywka@uke.uni-hamburg.deInstitute for Medical Microbiology and Immunology, University Hospital Eppendorf, 20246 Hamburg, Germany.
Journal of Clinical Microbiology
|April 3, 2001
Abstract:
Sera from 2,148 patients were tested with a third-generation microparticle enzyme immunoassay (MEIA), a confirmatory assay, and a reverse transcription-PCR. Overall, 85.6% of reactivities were confirmed, 13.2% were shown to be unspecifically reactive, and 1.2% were indeterminate. The rate of confirmed MEIA reactivities clearly depended on the strength of the reactivity.